Method for reducing pain of dermatological treatments
View Patent ↗A method of reducing the level of pain experienced by a patient during a pain-inducing dermatological treatment by using non-pharmacologic means is described. The method employs the use of multiple bursts of a gas to stimulate a touch sensation in or near the tissue to be treated using the dermatological treatment in order to reduce and/or relieve pain. The method can be used alone or can be used in combination with other non-pharmacologic and/or pharmacologic methods of relieving pain in order to make a patient more comfortable during or following the dermatological treatment.
1. A method of reducing the level of pain experienced by a patient during a pain-inducing dermatological treatment, comprising:
stimulating a touch sensation in a patient in an area in or near a region of tissue to be treated during a pain-inducing dermatological treatment,
wherein the stimulating of the touch sensation is achieved by directing multiple bursts of a gas at or near the region of tissue so as to reduce the level of pain experienced by the patient during the pain-inducing dermatological treatment.
2. The method of claim 1 , further comprising:
providing the pain-inducing dermatological treatment to a patient.
3. A method of reducing the dosage of anesthetic required by a patient undergoing a pain-inducing dermatological treatment, comprising:
stimulating a touch sensation in a patient in an area in or near a region of tissue to be treated during a pain-inducing dermatological treatment,
wherein the stimulating of the touch sensation is achieved by directing multiple bursts of a gas at or near the region of tissue, and
wherein the stimulating of the touch sensation reduces the dosage of anesthetic required to reduce the level of pain experienced by a patient undergoing the pain-inducing dermatological treatment.
4. The method of claim 3 , wherein the method comprises stimulating a touch sensation in the region of tissue to be treated by the pain-inducing dermatological treatment.
5. The method of claim 3 , wherein the method comprises stimulating a touch sensation in a region of tissue immediately adjacent to the region of tissue to be treated by the pain-inducing dermatological treatment.
6. The method of claim 3 , wherein the method comprises stimulating a touch sensation in a region of tissue which is larger than and encompasses the region of tissue to be treated by the pain-inducing dermatological treatment.
7. The method of claim 3 , wherein the region of tissue to be treated comprises human skin.
8. The method of claim 3 , wherein the multiple bursts of gas are delivered at a rate between about 5 bursts per second and about 100 bursts per second.
9. The method of claim 3 , wherein the multiple bursts of gas are delivered at a rate between about 5 bursts per second and about 50 bursts per second.
10. The method of claim 3 , wherein the multiple bursts of gas are delivered at a rate between about 10 bursts per second and about 30 bursts per second.
11. The method of claim 3 , wherein the multiple bursts of gas comprise bursts of pressurized gas.
12. The method of claim 3 , wherein the gas comprises air.
13. The method of claim 1 or 3 , wherein the gas comprises nitrogen.
14. The method of claim 3 , wherein the temperature of the gas is approximately ambient temperature as it contacts the tissue.
15. The method of claim 3 , wherein the temperature of the gas is between about 20° C. and about 30° C. as it contacts the tissue.
16. The method of claim 3 , wherein the temperature of the gas is below about 20° C. as it contacts the tissue.
17. The method of claim 3 , wherein the temperature of the gas is above about 30° C. as it contacts the tissue.
18. The method of claim 3 , wherein the pain-inducing dermatological treatment comprises an optical energy based treatment.
19. The method of claim 3 , wherein the pain-inducing dermatological treatment comprises a laser treatment.
20. The method of claim 3 , wherein the average pain score experienced by a patient undergoing the pain-inducing dermatological treatment in conjunction with the stimulating is at least 1 point less on a 10 point pain scale than the average pain score experienced by a patient undergoing the pain-inducing dermatological treatment in the absence of the stimulating, where a score of zero is no pain and a score of 10 is the worst pain imaginable.
21. The method of claim 20 , wherein the topical anesthetic is selected from the group consisting of lidocaine, prilocaine, tetracaine, benzocaine, dibucaine, oxybuprocaine, pramoxine, proparacaine, proxymetacaine, and combinations thereof.
22. The method of claim 3 , wherein the average pain score experienced by a patient undergoing the pain-inducing dermatological treatment in conjunction with the stimulating is at least 2 points less on a 10 point pain scale than the average pain score experienced by a patient undergoing the pain-inducing dermatological treatment in the absence of the stimulating, where a score of zero is no pain and a score of 10 is the worst pain imaginable.
23. The method of claim 3 , wherein the anesthetic comprises a topical anesthetic.
24. The method of claim 3 , wherein the dosage of anesthetic required to reduce the level of pain experienced by a patient undergoing the pain-inducing dermatological treatment in conjunction with the stimulating is at least 20% less than the dosage of anesthetic required to reduce the level of pain experienced by a patient undergoing the pain-inducing dermatological treatment in the absence of the stimulating.
25. The method of claim 24 , wherein a dosage of anesthetic required to reduce the level of pain experienced by a patient undergoing the pain-inducing dermatological treatment in the absence of the stimulating comprises the dosage of anesthetic required to prevent the patient from experiencing pain in excess of a pain score of 8 on a 10 point pain scale, where a score of zero is no pain and a score of 10 is the worst pain imaginable.
26. The method of claim 3 , further comprising:
providing the pain-inducing dermatological treatment to a patient.